reViral

reViral

reViral

reViral is a biotechnology company that develops and offers antiviral therapies for patients.
Raised
$55M
Follow us
Alexa global traffic share
Latest funding
$55,000,000
Venture capital (Series B) - 2018
New Leaf Venture Partners Perceptive Advisors OrbiMed +3
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when reViral makes some noise.